Laila Agrawal, MD IF
lailaagrawalmd.bsky.social
Laila Agrawal, MD IF
@lailaagrawalmd.bsky.social
90 followers 170 following 10 posts
Medical oncologist @ Norton Cancer Institute, Louisville KY Breast cancer specialist | Sexual health after cancer | Community onc | Opinions my own
Posts Media Videos Starter Packs
Part 2⃣Studies of HRT in breast cancer coming in 🔥🔥🔥@ASCO #ASCO25!!

Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.

Fewer hot flashes 🥵, more dizziness 😵‍💫
Studies of HRT in breast cancer coming in 🔥🔥🔥 #[email protected]

🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.

Sets the stage for more studies of CE/BZA in #bcsm
VERITAC-2: Vepdegestrant showed improved progression free survival in metastatic breast cancer with ESR1 mutation 🧬

As a community oncologist, thrilled that we could offer this trial to our patients close to their homes 🏠 and now see it published today in @nejm.org and presented at #ASCO25

#bcsm
nejm.org NEJM.org @nejm.org · May 31
In advanced breast cancer, progression-free survival was significantly longer with vepdegestrant than with fulvestrant among patients with ESR1 mutations but not in the full patient population. Full VERITAC-2 phase 3 trial results: nej.md/3ZoCL7g

#ASCO25 @ascocancer.bsky.social
Impressive overall survival benefit with the addition of inavolisib to palbo-fulvestrant in PIK3CA mutated 🧬 HR+ metastatic breast cancer in the INAVO120 study published in @nejm.org today and presented at #ASCO25

⬆️ hyperglycemia, stomatitis, GI and 👁️ side effects

#bcsm @oncoalert.bsky.social
nejm.org NEJM.org @nejm.org · May 31
INAVO120 trial: In patients with PIK3CA-mutated advanced breast cancer, inavolisib added to palbociclib–fulvestrant led to a significant overall survival benefit, with a higher incidence of certain toxic effects than placebo. nej.md/3Zje7Vt

#ASCO25 @ascocancer.bsky.social
Reposted by Laila Agrawal, MD IF
Great presentation by Dr Bauman at #ASCO25 highlights that there are many ways patients make decisions, with different priorities for their care.
Reposted by Laila Agrawal, MD IF
Kicked off Day 2 of #ASCO25 with coffee in the Advocate Lounge
Now looking forward to this session on facilitating informed discussions around evidence-based supportive care
Congratulations! You have made an impact on so many people including me!
Don’t miss our session on sexual health at #ASCO25 with @lizoriordan.bsky.social and Lawrence Jenkins.
So much great research coming out at #ASCO25 that will have a major impact for patients with #breastcancer

And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸

@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
Reposted by Laila Agrawal, MD IF
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸

@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
Thank you for highlighting our 📕chapter on sexual health! @ascocancer.bsky.social @lizoriordan.bsky.social
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
Reposted by Laila Agrawal, MD IF
This 👇🏾 is for every #oncology clinician who treats #AYA.

Seriously actionable practical education and care offered in this piece. BRAVO @lailaagrawalmd.bsky.social et. al

#AYACSM #sexualhealth #lateandlongterm
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
Reposted by Laila Agrawal, MD IF
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
Reposted by Laila Agrawal, MD IF
Reposted by Laila Agrawal, MD IF
Hot tips from #ASCOAdvocacySummit #ASCOAdvocacy:

A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared.

Preach! 🙌🏻 🗣️
@ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social